Evolution and applications of bioimpedance in managing chronic kidney disease
Evolución y aplicaciones de la bioimpedancia en el manejo de la enfermedad renal crónica
Read
15862
Timeswas read the article
3675
Total PDF
12187
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 63 | 45 | 108 |
| 2025 5 | 201 | 42 | 243 |
| 2025 4 | 183 | 30 | 213 |
| 2025 3 | 175 | 61 | 236 |
| 2025 2 | 125 | 39 | 164 |
| 2025 1 | 93 | 33 | 126 |
| 2024 12 | 80 | 32 | 112 |
| 2024 11 | 81 | 63 | 144 |
| 2024 10 | 71 | 43 | 114 |
| 2024 9 | 112 | 36 | 148 |
| 2024 8 | 97 | 65 | 162 |
| 2024 7 | 73 | 35 | 108 |
| 2024 6 | 93 | 55 | 148 |
| 2024 5 | 139 | 48 | 187 |
| 2024 4 | 89 | 35 | 124 |
| 2024 3 | 71 | 26 | 97 |
| 2024 2 | 82 | 44 | 126 |
| 2024 1 | 73 | 30 | 103 |
| 2023 12 | 55 | 27 | 82 |
| 2023 11 | 89 | 39 | 128 |
| 2023 10 | 109 | 58 | 167 |
| 2023 9 | 86 | 42 | 128 |
| 2023 8 | 70 | 40 | 110 |
| 2023 7 | 88 | 41 | 129 |
| 2023 6 | 90 | 35 | 125 |
| 2023 5 | 79 | 36 | 115 |
| 2023 4 | 65 | 34 | 99 |
| 2023 3 | 98 | 34 | 132 |
| 2023 2 | 92 | 39 | 131 |
| 2023 1 | 76 | 32 | 108 |
| 2022 12 | 105 | 35 | 140 |
| 2022 11 | 87 | 54 | 141 |
| 2022 10 | 118 | 60 | 178 |
| 2022 9 | 62 | 52 | 114 |
| 2022 8 | 62 | 54 | 116 |
| 2022 7 | 67 | 48 | 115 |
| 2022 6 | 75 | 48 | 123 |
| 2022 5 | 97 | 58 | 155 |
| 2022 4 | 128 | 75 | 203 |
| 2022 3 | 76 | 63 | 139 |
| 2022 2 | 66 | 65 | 131 |
| 2022 1 | 86 | 37 | 123 |
| 2021 12 | 55 | 34 | 89 |
| 2021 11 | 110 | 41 | 151 |
| 2021 10 | 106 | 66 | 172 |
| 2021 9 | 104 | 55 | 159 |
| 2021 8 | 147 | 46 | 193 |
| 2021 7 | 122 | 45 | 167 |
| 2021 6 | 99 | 41 | 140 |
| 2021 5 | 113 | 50 | 163 |
| 2021 4 | 201 | 76 | 277 |
| 2021 3 | 135 | 82 | 217 |
| 2021 2 | 93 | 39 | 132 |
| 2021 1 | 89 | 58 | 147 |
| 2020 12 | 80 | 22 | 102 |
| 2020 11 | 60 | 26 | 86 |
| 2020 10 | 74 | 30 | 104 |
| 2020 9 | 66 | 21 | 87 |
| 2020 8 | 65 | 28 | 93 |
| 2020 7 | 75 | 23 | 98 |
| 2020 6 | 97 | 25 | 122 |
| 2020 5 | 88 | 31 | 119 |
| 2020 4 | 97 | 30 | 127 |
| 2020 3 | 101 | 30 | 131 |
| 2020 2 | 121 | 39 | 160 |
| 2020 1 | 90 | 23 | 113 |
| 2019 12 | 106 | 41 | 147 |
| 2019 11 | 71 | 36 | 107 |
| 2019 10 | 64 | 26 | 90 |
| 2019 9 | 98 | 30 | 128 |
| 2019 8 | 75 | 27 | 102 |
| 2019 7 | 78 | 30 | 108 |
| 2019 6 | 79 | 38 | 117 |
| 2019 5 | 103 | 17 | 120 |
| 2019 4 | 143 | 42 | 185 |
| 2019 3 | 71 | 31 | 102 |
| 2019 2 | 49 | 43 | 92 |
| 2019 1 | 36 | 31 | 67 |
| 2018 12 | 149 | 36 | 185 |
| 2018 11 | 139 | 21 | 160 |
| 2018 10 | 138 | 20 | 158 |
| 2018 9 | 114 | 21 | 135 |
| 2018 8 | 81 | 14 | 95 |
| 2018 7 | 71 | 13 | 84 |
| 2018 6 | 68 | 14 | 82 |
| 2018 5 | 65 | 12 | 77 |
| 2018 4 | 98 | 9 | 107 |
| 2018 3 | 81 | 14 | 95 |
| 2018 2 | 86 | 9 | 95 |
| 2018 1 | 84 | 9 | 93 |
| 2017 12 | 85 | 15 | 100 |
| 2017 11 | 102 | 16 | 118 |
| 2017 10 | 70 | 17 | 87 |
| 2017 9 | 74 | 17 | 91 |
| 2017 8 | 62 | 22 | 84 |
| 2017 7 | 74 | 18 | 92 |
| 2017 6 | 82 | 13 | 95 |
| 2017 5 | 89 | 10 | 99 |
| 2017 4 | 84 | 14 | 98 |
| 2017 3 | 78 | 10 | 88 |
| 2017 2 | 120 | 13 | 133 |
| 2017 1 | 55 | 17 | 72 |
| 2016 12 | 79 | 6 | 85 |
| 2016 11 | 115 | 17 | 132 |
| 2016 10 | 175 | 12 | 187 |
| 2016 9 | 262 | 9 | 271 |
| 2016 8 | 258 | 13 | 271 |
| 2016 7 | 264 | 23 | 287 |
| 2016 6 | 159 | 0 | 159 |
| 2016 5 | 189 | 0 | 189 |
| 2016 4 | 149 | 0 | 149 |
| 2016 3 | 104 | 0 | 104 |
| 2016 2 | 129 | 0 | 129 |
| 2016 1 | 113 | 0 | 113 |
| 2015 12 | 145 | 0 | 145 |
| 2015 11 | 104 | 0 | 104 |
| 2015 10 | 101 | 0 | 101 |
| 2015 9 | 88 | 0 | 88 |
| 2015 8 | 81 | 0 | 81 |
| 2015 7 | 91 | 0 | 91 |
| 2015 6 | 64 | 0 | 64 |
| 2015 5 | 72 | 0 | 72 |
| 2015 4 | 8 | 0 | 8 |
Show all
